The Corporate Reputation of Pharma Industry - The Patient Perspective in 2015 - Eastern Europe Edition

  • ID: 3942549
  • Report
  • Region: Eastern Europe, Europe
  • 50 pages
  • PatientView
1 of 4

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Gedeon Richter
  • Lilly
  • Novo Nordisk
  • Sandoz
  • MORE

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 93 patient groups in 2015, focusing on differing medical specialties. The report provides feedback on the corporate reputation of the Eastern-European pharma industry during 2015, as well as the performance of 19 pharma companies for six key indicators that influence corporate reputation. Results are compared with those of the previous year.

Profiles Of the 19 Companies, According To the Patient Groups in Eastern Europe Familiar with These Companies, or Have Worked With Them

Each profile contains 

Company Background Information

  • Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
  • The profiled company’s main treatment subject areas (and areas of R&D).
  • A mission statement from the profiled company.

How the Company Has Performed At Six Indicators of Corporate Reputation

  • The profiled company’s performance at the six indicators of corporate reputation in 2015, according to the patient groups in Eastern Europe familiar with the company.
  • The profiled company’s performance at the six indicators of corporate reputation, according to the patient groups in Eastern Europe that have worked with the company.
  • How the profiled company performed in Eastern Europe for different therapy areas, compared with the company’s averages in Eastern Europe across all therapy areas in 2015.
  • How the profiled company performed in Eastern Europe for different countries/regions, compared with the company’s averages in Eastern Europe in 2015.

How the Company Ranks For Corporate Reputation Compared With Other Companies

  • The profiled company’s rankings in Eastern Europe in 2015 for the six indicators of corporate reputation, compared with 18 other companies 
  • The profiled company’s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies

Profile of the Patient Groups Familiar with the Company

  • Other companies that partner with a significant number of the profiled company’s partner patient groups.
  • The therapy areas and countries of the patient groups familiar with the profiled company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • Bayer
  • Gedeon Richter
  • Lilly
  • Novo Nordisk
  • Sandoz
  • MORE

ABOUT THIS REPORT

WHAT DID PATIENT GROUPS IN EASTERN EUROPE SAY ABOUT PHARMA IN 2015

  • Summary of the industry-wide findings in Eastern Europe

SOME POINTS ABOUT THE EASTERN-EUROPEAN CORPORATE RANKINGS

WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION

A FEW COMMENTS FROM PATIENT GROUPS IN EASTERN EUROPE, 2015

METHODOLOGY OF THE PATIENT-GROUP SURVEY

APPENDIX 1: Data on how patient groups in Eastern Europe see the pharmaceutical industry in 2015
APPENDIX 2: Rankings of the 19 pharma companies for each of the 6 indicators of corporate reputation, as perceived by patient groups in Eastern Europe in 2015
APPENDIX 3: Profiles of the 19 companies
APPENDIX 4: Profiles of the 93 respondent patient groups from Eastern Europe

LIST OF TABLES AND CHARTS—BASED ON THE VIEWS OF PATIENT GROUPS IN EASTERN EUROPE
Percentage of patient groups in Eastern Europe claiming familiarity with the company
Percentage of patient groups in Eastern Europe claiming familiarity, and which also worked with the company
Percentage of patient groups worldwide (by geographic region) stating that the pharma industry had an “Excellent” or “Good” corporate reputation in 2015
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at BEING INNOVATIVE
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at PRODUCING HIGH QUALITY PRODUCTS
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at MANAGING ADVERSE NEWS ABOUT PRODUCTS
% of patient groups (by geographic region) stating that pharma is “Excellent” or “Good” at HAVING FAIR PRICING POLICIES
Final ranking of pharma companies for corporate reputation in 2015, according to patient groups based in Eastern Europe, v. final ranking in Eastern Europe in 2015
The percentage of patient groups from three Eastern-European countries that said pharma had an “Excellent” or “Good” corporate reputation in 2015
If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single
strategy from the list below do you think would be MOST IMPORTANT for the company to follow Please select only ONE option
How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015
What do you think has happened to the corporate reputation of the pharma industry over the past five years
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which
influence their corporate standing with patients and patient groups in Eastern Europe)
Companies with the most effective patient-centred strategy (rankings of 19 companies, 2015)
Companies providing the best high-quality patient information (rankings of 19 companies, 2015)
Companies with the best record on patient safety (rankings of 19 companies, 2015)
Companies with the most-useful high-quality products (rankings of 19 companies, 2015)
Companies with the best record of transparency (rankings of 19 companies, 2015)
Companies with the best record on integrity (rankings of 19 companies, 2015)
Rankings of the 19 pharmaceutical companies in Eastern Europe, 2015 v. 2014, ALPHABETIC ORDER
Rankings of the 19 pharmaceutical companies in Eastern Europe, 2015 v. 2014, HIGHEST TO LOWEST
Profile of 2015’s 93 respondent patient groups based in Eastern Europe—by country
Geographic remit of 2015’s 93 respondent patient groups based in Eastern Europe
Profile of 2015’s 93 respondent patient groups based in Eastern Europe—by therapy area

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Gedeon Richter
  • GSK
  • Janssen
  • Lilly
  • Merck & Co
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • Servier
  • Teva
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll